相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn et al.
PAIN PRACTICE (2012)
Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
M. Pirmohamed et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim et al.
EPILEPSY RESEARCH (2011)
Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
Yan Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Drug hypersensitivity: Pharmacogenetics and clinical syndromes
Elizabeth J. Phillips et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
Pei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
Qian Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
HLA-B*1502 screening: Time to clinical practice
Chaichon Locharernkul et al.
EPILEPSIA (2010)
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
Nahoko Kaniwa et al.
EPILEPSIA (2010)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
Hiroko Ikeda et al.
EPILEPSIA (2010)
Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
X. T. Wu et al.
EPILEPSY & BEHAVIOR (2010)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients
Mariko Kashiwagi et al.
JOURNAL OF DERMATOLOGY (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
Methodological quality of pharmacogenetic studies: Issues of concern
Andrea L. Jorgensen et al.
STATISTICS IN MEDICINE (2008)
Human leukocyte antigens and drug hypersensitivity
Wen-Hung Chung et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Generation and characterization of antigen-specific CD4(+), CD8(+), and CD4(+)CD8(+) T-cell clones from patients with carbamazopine hypersensitivity
Ying Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
Ana Alfirevic et al.
PHARMACOGENOMICS (2006)
Toxic epidermal necrolysis and Stevens-Johnson syndrome - Does early withdrawal of causative drugs decrease the risk of death?
I Garcia-Doval et al.
ARCHIVES OF DERMATOLOGY (2000)
分享论文
